Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

2.2K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Amyloid β Instigates Cardiac Neurotrophic Signaling Impairment, Driving Alzheimer's Associated Heart Disease.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

β3AR-Dependent Brain-Derived Neurotrophic Factor (BDNF) Generation Limits Chronic Postischemic Heart Failure.

Circulation research·2023
Same author

RNA-Binding Protein LIN28a Regulates New Myocyte Formation in the Heart Through Long Noncoding RNA-H19.

Circulation·2022
Same author

Extracellular vesicle-mediated bidirectional communication between heart and other organs.

American journal of physiology. Heart and circulatory physiology·2022
Same author

Cell Surface and Functional Features of Cortical Bone Stem Cells.

International journal of molecular sciences·2021
Same author

Cortical bone stem cells modify cardiac inflammation after myocardial infarction by inducing a novel macrophage phenotype.

American journal of physiology. Heart and circulatory physiology·2021

Related Experiment Video

Updated: Jul 25, 2025

Simultaneous Assessment of Cardiomyocyte DNA Synthesis and Ploidy: A Method to Assist Quantification of Cardiomyocyte Regeneration and Turnover
08:03

Simultaneous Assessment of Cardiomyocyte DNA Synthesis and Ploidy: A Method to Assist Quantification of Cardiomyocyte Regeneration and Turnover

Published on: May 23, 2016

10.4K

Cardiomyocyte Ploidy, Metabolic Reprogramming and Heart Repair.

Andrea Elia1, Sadia Mohsin2, Mohsin Khan1,3

  • 1Center for Metabolic Disease Research, Lewis Katz School of Medicine, Temple University, Philadelphia, PA 19140, USA.

Cells
|June 28, 2023
PubMed
Summary
This summary is machine-generated.

Heart muscle cells (cardiomyocytes) normally cannot divide. Metabolic changes influence cardiomyocyte division and regeneration after heart injury, offering new therapeutic avenues.

Keywords:
binucleationcardiomyocytecell cyclemetabolismploidy

More Related Videos

Isolation of Cardiomyocytes from Fixed Hearts for Immunocytochemistry and Ploidy Analysis
08:41

Isolation of Cardiomyocytes from Fixed Hearts for Immunocytochemistry and Ploidy Analysis

Published on: October 7, 2020

7.1K
Assessing Cardiomyocyte Subtypes Following Transcription Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts
09:29

Assessing Cardiomyocyte Subtypes Following Transcription Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts

Published on: March 22, 2017

7.5K

Related Experiment Videos

Last Updated: Jul 25, 2025

Simultaneous Assessment of Cardiomyocyte DNA Synthesis and Ploidy: A Method to Assist Quantification of Cardiomyocyte Regeneration and Turnover
08:03

Simultaneous Assessment of Cardiomyocyte DNA Synthesis and Ploidy: A Method to Assist Quantification of Cardiomyocyte Regeneration and Turnover

Published on: May 23, 2016

10.4K
Isolation of Cardiomyocytes from Fixed Hearts for Immunocytochemistry and Ploidy Analysis
08:41

Isolation of Cardiomyocytes from Fixed Hearts for Immunocytochemistry and Ploidy Analysis

Published on: October 7, 2020

7.1K
Assessing Cardiomyocyte Subtypes Following Transcription Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts
09:29

Assessing Cardiomyocyte Subtypes Following Transcription Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts

Published on: March 22, 2017

7.5K

Area of Science:

  • Cardiovascular Biology
  • Cellular Metabolism
  • Regenerative Medicine

Background:

  • Adult cardiomyocytes (CMs) are terminally differentiated and lack regenerative capacity after myocardial injury.
  • Developing CMs are proliferative and contribute to cardiac tissue regeneration.
  • CM maturation involves polyploidization and binucleation, altering function and metabolism.

Purpose of the Study:

  • To review changes in cardiomyocyte ploidy and nucleation during cardiac development, maturation, and injury.
  • To explore the role of metabolic reprogramming in CM cell cycle reentry and fate transitions.
  • To discuss the impact of metabolism on CM proliferation and cardiac regeneration.

Main Methods:

  • Literature review of studies on cardiomyocyte development, maturation, and response to injury.
  • Analysis of research on metabolic changes associated with CM ploidy and nucleation.
  • Synthesis of findings on the link between metabolism, cell cycle, and cardiac regeneration.

Main Results:

  • CMs transition from mononucleated diploid to polyploid/binucleated states during maturation.
  • Metabolic reprogramming is crucial for CM cell cycle reentry and ploidy changes.
  • These metabolic and cellular changes enhance cardiac structure and function post-injury.

Conclusions:

  • Metabolism significantly influences cardiomyocyte fate, including mononucleation/binucleation and cell cycle progression.
  • Understanding these metabolic-cardiomyocyte interactions is key to promoting cardiac regeneration.
  • Targeting metabolic pathways may offer novel strategies for treating heart disease.